Kei Fujiwara - Concepedia

Author

Kei Fujiwara

Also Known As

Fujiwara, Kanta, J. Ignatius, K FUJIWARA, K Fujiwara, K. FUJIWARA, K. Fujiwara, K., Fujiwara, KEI FUJIWARA, Kanta Fujiwara, Kei Fujiwara

111

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Nagoya City University Japanese Red Cross Nagoya Daini Hospital Nagoya City University Hospital Nagoya Medical Center Toyokawa City Hospital

About

Kei Fujiwara is an author at Nagoya City University specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	564
2	Health Sciences	1	1	51
3	Natural Sciences	1	1	23
4	Public Health	1	1	176
5	Allergy	1	1	11

Kei Fujiwara

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Gut Dysbiosis Associated With Hepatitis C Virus Infection Takako Inoue, Jiro Nakayama, Kei Moriya, Clinical Infectious Diseases	2018	183
A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon Fuat Kurbanov, Yasuhito Tanaka, Kei Fujiwara, Journal of General Virology Viral DiagnosticsHepatitis BHepatitis B VirusGenotypes AViral Evolution	2005	176
Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System Takanobu Kato, Tomoko Date, Michiko Miyamoto, Journal of Clinical Microbiology Viral ReplicationMolecular VirologyHepatologyHepatitis CViral Hepatitis	2005	98
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson, The Lancet. Gastroenterology & hepatology Ide AnaloguesViral HepatitisMedicineImmunologyAntiviral Drug Development	2023	64
T1653 Mutation in the Box a Increases the Riskof Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Genotype C Infection Kiyoaki Ito, Yasuhito Tanaka, Etsuro Orito, Clinical Infectious Diseases	2005	58
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B Akihiro Matsumoto, Eiji Tanaka, Yoshiyuki Suzuki, Hepatology Research	2011	57
Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial Shunsuke Nojiri, Kei Fujiwara, Noboru Shinkai, Nutrition HepatologyRadiofrequency AblationMedicineLiver PhysiologyRandomized Trial	2016	51
Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1 Etsuko Iio, Noritomo Shimada, Hiroshi Abe, Journal of Gastroenterology Genotype 1HepatologyHepatitis CViral HepatitisImmunology	2016	43
Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus Takako Inoue, Takaaki Goto, Etsuko Iio, Hepatology Research	2017	41
Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E Kei Fujiwara World Journal of Gastroenterology	2005	39

Page 1